|
Yebra, M; Goretzki, L; Pfeifer, M et al. (1999) Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 250:231-40
|
|
Mueller, B M; Ruf, W (1998) Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 101:1372-8
|
|
Ott, I; Fischer, E G; Miyagi, Y et al. (1998) A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140:1241-53
|
|
Goretzki, L; Mueller, B M (1998) Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem J 336 ( Pt 2):381-6
|
|
Stahl, A; Mueller, B M (1997) Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system. Int J Cancer 71:116-22
|
|
DeClerck, Y A; Imren, S; Montgomery, A M et al. (1997) Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol 425:89-97
|
|
Goretzki, L; Mueller, B M (1997) Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase. J Cell Sci 110 ( Pt 12):1395-402
|
|
Ruf, W; Mueller, B M (1996) Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 3:379-84
|
|
Stahl, A; Mueller, B M (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129:335-44
|
|
Mueller, B M; Yu, Y B; Laug, W E (1995) Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci U S A 92:205-9
|
Showing the most recent 10 out of 11 publications
